Editorial · 30 Nov 2024
Conference abstractPublished 16 Aug 2023
A neutrophil-related gene signature predicts immune status and sensitivity to nuclear receptor-targeting agents in triple-negative breast cancer
Hunan Normal University, China
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Purpose: To develop a neutrophil-related gene signature that can be used to predict survival outcomes and identify potential therapeutic drugs for Triple-Negative Breast Cancer (TNBC) patients. Design: iTRAQ-based proteomics analysis of breast cancer tissues and bioinformatics analysis of the TCGA-BRCA dataset were performed to evaluate the pathways enriched in TNBC. Immunohistochemistry was used to determine neutrophil infiltration in TNBC. Univariate and multivariate Cox analyses were performed on TNBC patients from TCGA-BRCA dataset to derive a Neutrophil-Related Gene Signature (NRGS). A nomogram model was generated to predict survival outcomes of TNBC patients. A Gene Expression Omnibus (GEO) dataset was used for independent validation. The NRGS was analyzed for tumor immune microenvironment and response to immune checkpoint inhibitors as well as sensitivity to therapeutic drugs. Results: Through iTRAQ-based proteomics profiling and TCGA-BRCA dataset mining, we found neutrophil-related pathways as the top enriched pathways in TNBC. A higher level of neutrophil infiltration was demonstrated by immunohistochemistry on TNBC compared with non-TNBC tissues. A 9-gene NRGS was identified and used to derive a risk score to stratify TNBC patients into high- and low-risk groups. A nomogram model with superior predicting power was generated via incorporating the NRGS with clinicopathological parameters. High-risk TNBC patients were associated with immune suppression and were less sensitive to immune checkpoint inhibitors. Furthermore, we found high-risk TNBC patients had enhanced sensitivity to nuclear receptor-targeting agents [Figure 1]. Conclusion: A neutrophil-related gene signature could predict decreased sensitivity to immune checkpoint inhibitors but increased sensitivity to nuclear receptor-targeting agents in high-risk TNBC patients.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Breast Cancer: Current Research.
Editorial · 30 Nov 2024
Reconstructive Surgery Advancements Techniques and Impact on Patient Quality of Life
Editorial · 30 Nov 2024
Immunotherapy A Revolution in Cancer Treatment and Beyond
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalBreast Cancer: Current Research
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Muyao Wu”
- BylineArticles whose byline prints “Lian Xue”
- BylineArticles whose byline prints “Xi Xu”
- BylineArticles whose byline prints “Siyu Ding”
- BylineArticles whose byline prints “Guangchun He”
- BylineArticles whose byline prints “Chanjuan Zheng”
- BylineArticles whose byline prints “Xiyun Deng”